Therillia

0 followers


Therillia develops novel drug candidates of interest to preclinical to clinical proof of concept.

Industries

Headquarters

Employees

Links

Org chart

Michael Dixon
President & CEO

Michael Dixon

Collapse
Pierre Beauparlant
Chief Business Officer